Favorable effect of a 'second hit' after 13 weeks in early RA non-responders: The Amsterdam COBRA treat-to-target randomized trial.
Linda HartmanL A RaschS A TurkM M Ter WeeP J S M KerstensC J van der LakenM T NurmohamedD van SchaardenburgL H D van TuylA E VoskuylM BoersW F LemsPublished in: Rheumatology (Oxford, England) (2022)
Netherlands Trial Register (NTR): NL4393.